Invasive fungal disease in patients treated for newly diagnosed acute leukemia

American Journal of Hematology
Sarah P HammondLindsey R Baden

Abstract

Invasive fungal disease (IFD) is a significant cause of morbidity and mortality in patients undergoing treatment for acute leukemia (AL). Antifungal prophylactic strategies are associated with significant toxicities and cost. We performed a retrospective study of the incidence and risk factors for IFD among patients newly diagnosed with and treated for AL between January 1, 2004 and July 1, 2006. Patient follow up concluded January 1, 2007. Among 231 patients with newly diagnosed AL, 31 (13.4%) developed IFD by the end of follow up, 24 (10.4%) of whom developed IFD within the first 100 days after diagnosis of AL. The cumulative probability of developing IFD was 5.9% by 30 days and 11.1% at 100 days after AL diagnosis. Patients who had persistent leukemia after an initial course of induction chemotherapy were significantly more likely to develop IFD than those who did not have evidence of persistent leukemia (14/65 (21.5%) vs. 15/148 (10.1%), P = 0.03). In a time-dependent Cox model, the adjusted hazard ratio for developing IFD within the first 100 days of AL diagnosis based on the number of days of neutropenia in that period was 4.85 (95% confidence interval: 1.52, 15.4). Those patients with more days of neutropenia in the firs...Continue Reading

References

Feb 19, 2002·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·Walter T HughesLowell S Young
May 27, 2003·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·Yoshinari MyokenYuzuru Mikami
Sep 25, 2003·Blood·Kieren A MarrGeorge B McDonald
Dec 16, 2003·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Bruce D ChesonUNKNOWN International Working Group for Diagnosis, Standardization of Response Criteria, Treatment Outcomes, and Reporting Standards
Feb 27, 2004·The New England Journal of Medicine·Francisco M MartyLindsey R Baden
Mar 26, 2005·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·Laura CudilloPaolo de Fabritiis
Jan 28, 2006·International Journal of Infectious Diseases : IJID : Official Publication of the International Society for Infectious Diseases·Kenneth V I RolstonDah H Ho
Jan 26, 2007·The New England Journal of Medicine·Oliver A CornelyDavid Angulo-Gonzalez
Jan 26, 2007·The New England Journal of Medicine·Ben E De Pauw, J Peter Donnelly
May 8, 2007·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·Livio PaganoAnnamaria Nosari
Aug 11, 2007·European Journal of Clinical Microbiology & Infectious Diseases : Official Publication of the European Society of Clinical Microbiology·C RiegerH Ostermann
Oct 3, 2007·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Eyal RobenshtokMical Paul
May 9, 2008·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·Ben De PauwUNKNOWN National Institute of Allergy and Infectious Diseases Mycoses Study Group (EORTC/MSG) Consensus Group
Aug 30, 2008·Journal of Oncology Pharmacy Practice : Official Publication of the International Society of Oncology Pharmacy Practitioners·Joseph J Kishel, Jeffrey Sivik
Sep 30, 2009·Antimicrobial Agents and Chemotherapy·Paul A MannTodd A Black
Oct 30, 2009·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·Sophia KooFrancisco M Marty
Jan 6, 2010·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·Konstantinos LeventakosDimitrios P Kontoyiannis

❮ Previous
Next ❯

Citations

Oct 25, 2014·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·Sophia KooFrancisco M Marty
Mar 18, 2017·European Journal of Immunology·Mike FischerUlf Schnetzke
Mar 15, 2014·Current Opinion in Pulmonary Medicine·Alyssa R LetourneauLindsey R Baden
Aug 1, 2011·Therapeutic Advances in Hematology·Vijaya R BhattAlessandra Ferrajoli
Jun 6, 2019·Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer·Variya NganthaveePloyploen Phikulsod
Jan 6, 2018·The Journal of Antimicrobial Chemotherapy·David J EpsteinGenovefa A Papanicolaou
May 22, 2020·Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer·Andrew HsuDimitrios Farmakiotis
Jun 15, 2011·Current Opinion in Infectious Diseases·Victor E Mulanovich, Dimitrios P Kontoyiannis
Mar 9, 2021·Clinical Lymphoma, Myeloma & Leukemia·Pakpoom PhoompoungShahid Husain

❮ Previous
Next ❯

Related Concepts

Related Feeds

Antifungals

An antifungal, also known as an antimycotic medication, is a pharmaceutical fungicide or fungistatic used to treat and prevent mycosis such as athlete's foot, ringworm, candidiasis, cryptococcal meningitis, and others. Discover the latest research on antifungals here.

Antifungals (ASM)

An antifungal, also known as an antimycotic medication, is a pharmaceutical fungicide or fungistatic used to treat and prevent mycosis such as athlete's foot, ringworm, candidiasis, cryptococcal meningitis, and others. Discover the latest research on antifungals here.